PAPER Kok CC, Boyt A, Gaudieri S, Martins R, Askanas V, Dalakas M, Kiers L, Mastaglia F, Garlepp M
SEARCH RESULTS
337658 RESULTS
PAPER Lovell MA, Xie C, Markesbery WR
Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures.
Free Radic Biol Med. 2000 Oct 15;29(8):714-20. PubMed.PAPER Savaskan E, Müller-Spahn F, Olivieri G, Bruttel S, Otten U, Rosenberg C, Hulette C, Hock C
Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease.
Eur Neurol. 2000;44(3):172-80. PubMed.PAPER Castillo GM, Lukito W, Peskind E, Raskind M, Kirschner DA, Yee AG, Snow AD
Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
J Neurosci Res. 2000 Nov 1;62(3):451-62. PubMed.PAPER Flaherty DB, Soria JP, Tomasiewicz HG, Wood JG
Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.
J Neurosci Res. 2000 Nov 1;62(3):463-72. PubMed.PAPER Schindler RJ, Cucio CP
Late-life dementia. Review of the APA guidelines for patient management.
Geriatrics. 2000 Oct;55(10):55-60; quiz 62. PubMed.PAPER Macknight C
World Alzheimer Congress 2000.
Clin Invest Med. 2000 Oct;23(5):339-41. PubMed.PAPER Ksiezak-Reding H, He D, Gordon-Krajcer W, Kress Y, Lee S, Dickson DW
Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes.
Cell Motil Cytoskeleton. 2000 Nov;47(3):236-52. PubMed.PAPER Steiner H, Kostka M, Romig H, Basset G, Pesold B, Hardy J, Capell A, Meyn L, Grim ML, Baumeister R, Fechteler K, Haass C
Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases.
Nat Cell Biol. 2000 Nov;2(11):848-51. PubMed.PAPER Chu LW, Chiu KC, Hui SL, Yu GK, Tsui WJ, Lee PW
The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly Chinese in Hong Kong.
Ann Acad Med Singapore. 2000 Jul;29(4):474-85. PubMed.PAPER Korczyn AD
Muscarinic M(1) agonists in the treatment of Alzheimer's disease.
Expert Opin Investig Drugs. 2000 Oct;9(10):2259-67. PubMed.PAPER Sramek JJ, Frackiewicz EJ, Cutler NR
Review of the acetylcholinesterase inhibitor galanthamine.
Expert Opin Investig Drugs. 2000 Oct;9(10):2393-402. PubMed.PAPER Kumar-Singh S, De Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M, De Strooper B, Vanderstichele H, Löfgren A, Vanderhoeven I, Backhovens H, Vanmechelen E, Kroisel PM, Van Broeckhoven C
Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease.
Hum Mol Genet. 2000 Nov 1;9(18):2589-98. PubMed.PAPER Praticò D, Delanty N
Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease.
Am J Med. 2000 Nov;109(7):577-85. PubMed.PAPER Lambert JC, Mann D, Goumidi L, Harris J, Pasquier F, Frigard B, Cottel D, Lendon C, Iwatsubo T, Amouyel P, Chartier-Harlin MC
A FE65 polymorphism associated with risk of developing sporadic late-onset alzheimer's disease but not with Abeta loading in brains.
Neurosci Lett. 2000 Oct 20;293(1):29-32. PubMed.Current Filters
No filters selected